Ultra-short-course seasonal allergy vaccine (Pollinex Quattro): viewpoints.
Jutek
Marel
M
Department of Internal Medicine and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Bachert
Claus
C
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000485:Allergens / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D052179:Antigens, Plant / Q000627:therapeutic use; D001249:Asthma / Q000517:prevention & control / Q000628:therapy*; D003888:Desensitization, Immunologic / Q000379:methods*; D006801:Humans; D008050:Lipid A / Q000031:analogs & derivatives / Q000276:immunology / Q000627:therapeutic use; D010936:Plant Extracts / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D015203:Reproducibility of Results; D006255:Rhinitis, Allergic, Seasonal / Q000517:prevention & control / Q000628:therapy*; D014612:Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000485:Allergens; D052179:Antigens, Plant; D008050:Lipid A; D010936:Plant Extracts; D014612:Vaccines; C433085:ragweed pollen; C048436:monophosphoryl lipid A